Early Transmission Dynamics, Spread, and Genomic Characterization of SARS-CoV-2 in Panama
Danilo Franco
1, Claudia Gonzalez
1, Leyda E. Abrego
1, Jean-Paul Carrera, Yamilka Diaz, Yaset Caicedo, Ambar Moreno, Oris Chavarria, Jessica Gondola, Marlene Castillo, Elimelec Valdespino, Melissa Gaitán, Jose Martínez-Mandiche, Lizbeth Hayer, Pablo Gonzalez, Carmen Lange, Yadira Molto, Dalis Mojica, Ruben Ramos, Maria Mastelari, Lizbeth Cerezo, Lourdes Moreno, Christl A. Donnelly, Juan Miguel Pascale, Nuno Rodrigues Faria, Sandra Lopez-Verges
, Alexander A. Martinez, and
on behalf of Gorgas COVID19 team and Panama COVID19 Laboratory Network 3 -->
Author affiliations: Gorgas Memorial Institute of Health Studies, Panama City, Panama (D. Franco, C. Gonzalez, L.E. Abrego, J.-P. Carrera, Y. Diaz, A. Moreno, O. Chavarria, J. Gondola, M. Castillo, E. Valdespino, M. Gaitán, J. Martínez-Mandiche, D. Mojica, R. Ramos, J.M. Pascale, S. Lopez-Verges, A.A. Martinez); Universidad de Panama, Panama City (D. Franco, C. Gonzalez, L.E. Abrego, J.M. Pascale, S. Lopez-Verges, A.A. Martinez); Ministry of Health of Panama, Panama City (L. Hayer, P. Gonzalez, C. Lange, Y. Molto, M. Mastelari, L. Cerezo, L. Moreno); University of Oxford, Oxford, UK (J.-P. Carrera, C.A. Donnelly, N.R. Faria); Fundación Valle del Lili, Cali, Colombia (Y. Caicedo); Imperial College, London, UK (C.A. Donnelly, N.R. Faria)
Main Article
Figure 2
Figure 2. Genetic diversity of SARS-CoV-2 in Panama. A) Bayesian maximum clade credibility tree of 1,261 SARS-CoV-2 sequences: 133 from Panama; 492 from North or South America (443 genomes are from Brazil, 41 from the United States, 7 from Chile, 6 from Mexico, 3 from Argentina, 1 from Peru, and 1 from Canada); and 636 are from other locations. Posterior density estimates of time of the most recent common ancestor of each lineage with local transmission are shown in their branches. B) Distribution of lineages among regions in Panama. C) Distribution of lineages by channel of exposure detected by the surveillance system. SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Main Article
Page created: November 09, 2020
Page updated: January 23, 2021
Page reviewed: January 23, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.